|
|
|
|
|
|
|
7
6th Annual Single Cell Analysis USA Congress
The congress covers the latest in Multi-Omic Single Cell Analysis - discuss and debate the critical challenges and opportunities in Genomic, Transcriptomics and Proteomics. Updates and highlights in Spatial Transcriptomics, Genomics and Digital Spatial Profiling as well as implications on sample and data analysis. Latest advancements in single cell analysis in drug discovery and development including key therapeutic applications in oncology, neurology and immuno-oncology, and the latest diagnostics development. Overcoming Challenges in library preparation, bioinformatics and multi-omic data integration.
6th Annual Next Generation Sequencing USA Congress
350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies.
3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.
80+ case studies, solution & technology presentations & 2 interactive workshops.
07 April 2019 – Day One
- Discussion Workshop: Accuracy, cost and coverage of short and long read sequencing
- Future Directions In Long Read Sequencing For Human Genomes And De Novo Studies (part 1)
08 April 2019 – Day Two
- Future Directions In Long Read Sequencing For Human Genomes And De Novo Studies (part 2)
View Agenda: http://bit.ly/2QijaD2
4th Annual Genome Editing USA Congress
350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies.
3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.
80+ case studies, solution & technology presentations & 2 interactive workshops over the 2 days.
07 April 2019 – Day One
- Genome Editing Technologies & Techniques
- Drug Discovery & Development Applications in In Vivo Therapeutics
08 April 2019 – Day Two
- Drug Discovery & Development – Target Identification and Validation
- Non-Human Models in Diagnostics & Therapeutics
View Agenda: http://bit.ly/2rLMzeL
2020 Live Webinar
Chemically-Modified Polynucleotides for Inhibiting, Expressing and Repairing Nucleic Acids: Then & Now
Presented by Tod Woolf, Founder & CEO, ETAGEN Pharma, Inc.
Tuesday, 10 March 2020 | 03:30 PM GMT
Register: https://bit.ly/2QvO7Us
|
8
6th Annual Single Cell Analysis USA Congress
The congress covers the latest in Multi-Omic Single Cell Analysis - discuss and debate the critical challenges and opportunities in Genomic, Transcriptomics and Proteomics. Updates and highlights in Spatial Transcriptomics, Genomics and Digital Spatial Profiling as well as implications on sample and data analysis. Latest advancements in single cell analysis in drug discovery and development including key therapeutic applications in oncology, neurology and immuno-oncology, and the latest diagnostics development. Overcoming Challenges in library preparation, bioinformatics and multi-omic data integration.
6th Annual Next Generation Sequencing USA Congress
350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies.
3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.
80+ case studies, solution & technology presentations & 2 interactive workshops.
07 April 2019 – Day One
- Discussion Workshop: Accuracy, cost and coverage of short and long read sequencing
- Future Directions In Long Read Sequencing For Human Genomes And De Novo Studies (part 1)
08 April 2019 – Day Two
- Future Directions In Long Read Sequencing For Human Genomes And De Novo Studies (part 2)
View Agenda: http://bit.ly/2QijaD2
4th Annual Genome Editing USA Congress
350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies.
3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.
80+ case studies, solution & technology presentations & 2 interactive workshops over the 2 days.
07 April 2019 – Day One
- Genome Editing Technologies & Techniques
- Drug Discovery & Development Applications in In Vivo Therapeutics
08 April 2019 – Day Two
- Drug Discovery & Development – Target Identification and Validation
- Non-Human Models in Diagnostics & Therapeutics
View Agenda: http://bit.ly/2rLMzeL
2020 Live Webinar
Chemically-Modified Polynucleotides for Inhibiting, Expressing and Repairing Nucleic Acids: Then & Now
Presented by Tod Woolf, Founder & CEO, ETAGEN Pharma, Inc.
Tuesday, 10 March 2020 | 03:30 PM GMT
Register: https://bit.ly/2QvO7Us
|
|
|
|
|
|
14
Patient Data Summit
A new event brought to you from Corinium, the data & analytics experts, this summit will focus on how the field is developing within healthcare and how companies can set standards to stay ahead of the curve.
More specifically, we will examine how data & analytics can improve the patient experience and overall lifetime care.
This event will incorporate a range of keynote presentations, panel discussions with small group conversations centered around what you and your peers need to consider now.
2020 Speakers include:
-
Greg Robinson, SVP/CDAO, MARSHFIELD CLINIC HEALTH SYSTEM/ SECURITY HEALTH PLAN
-
Besa Bauta, CDO, MERCYFIRST
-
Steve Stepp, VP, Analytics, CATHOLIC HEALTH SERVICES
-
Morgan Templar, VP, Data Management & Analytics, HIGHMARK HEALTH SOLUTIONS
-
Kamayini Kaul, Executive Director, Enterprise Information Strategy & Risk Management, BRISTOL-MYERS SQUIBB
-
Varun Gupta, IT Director, Advanced Analytics & Data Management, MOUNT SINAI HEALTH SYSTEM
-
Timothy Carey, Director of Data & Performance Analytics, BANE CARE MANAGEMENT
-
Maryann Small, Director of Data Governance, COVERYS
-
Kevin Yebuah, Supervisor, Data Analytics & Reporting, KERN HEALTH SYSTEMS
...and many more!
CHECK OUT THE LATEST AGENDA FOR THE FULL LINE-UP: http://bit.ly/2uQoyEY
REGISTER WITH PROMO CODE ‘BioPharma100’ to save $100: http://bit.ly/3aZGLQL
For more information about the event, including additional participation options and team discounts, please contact inquiries@coriniumintel.com
|
|
|
|
|
|
|
|
|
|
|
|
|
27
7th Annual Peptides & Oligonucleotides Congress
With major developments in the peptide field and with more and more peptide and oligonucleotide therapeutics entering clinical trials, the real promise of peptides and oligonucleotides is starting to be realised. Part of our Biologics Series, this event will take you through the key stages of peptide development from peptide discovery through to formulation and delivery, manufacturing and synthesis, as well as oligonucleotide synthesis, chemistry, formulation, as well as therapeutics and manufacturing.
2nd Annual Bispecifics in Discovery & Development Congress
Oxford Global’s 2nd Annual Bispecifics in Discovery & Development Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.
New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.
13th Annual Proteins & Antibodies Congress
Oxford Global’s 13th Annual Proteins & Antibodies Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.
New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.
|
28
7th Annual Peptides & Oligonucleotides Congress
With major developments in the peptide field and with more and more peptide and oligonucleotide therapeutics entering clinical trials, the real promise of peptides and oligonucleotides is starting to be realised. Part of our Biologics Series, this event will take you through the key stages of peptide development from peptide discovery through to formulation and delivery, manufacturing and synthesis, as well as oligonucleotide synthesis, chemistry, formulation, as well as therapeutics and manufacturing.
2nd Annual Bispecifics in Discovery & Development Congress
Oxford Global’s 2nd Annual Bispecifics in Discovery & Development Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.
New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.
13th Annual Proteins & Antibodies Congress
Oxford Global’s 13th Annual Proteins & Antibodies Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.
New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.
|
29
7th Annual Peptides & Oligonucleotides Congress
With major developments in the peptide field and with more and more peptide and oligonucleotide therapeutics entering clinical trials, the real promise of peptides and oligonucleotides is starting to be realised. Part of our Biologics Series, this event will take you through the key stages of peptide development from peptide discovery through to formulation and delivery, manufacturing and synthesis, as well as oligonucleotide synthesis, chemistry, formulation, as well as therapeutics and manufacturing.
2nd Annual Bispecifics in Discovery & Development Congress
Oxford Global’s 2nd Annual Bispecifics in Discovery & Development Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.
New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.
13th Annual Proteins & Antibodies Congress
Oxford Global’s 13th Annual Proteins & Antibodies Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.
New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.
|
|
|
|
|
|